Quercetin-biapigenin nanoparticles are effective to penetrate the blood–brain barrier
- 11 March 2021
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 12 (1) , 267-281
Abstract
Search for efficient therapeutic agents for central nervous system (CNS) disorders has been extensive. Nevertheless, blood–brain barrier (BBB) is an obstacle that prevents the majority of compounds to act in these diseases. It is, thus, of extreme relevance the BBB overcome, in order to deliver a drugs therapeutically active concentration to the action site, with the least losses and interaction with other organs, tissues, or cells. The present study aimed to investigate the potential protective effect of quercetin-biapigenin encapsulated into poly(Ɛ-polycaprolactone) (PCL) nanoparticles against t-BOOH-induced oxidative stress in several brain cell lines, as well as evaluate the permeability of those active molecules through an in vitro BBB model. The three cell lines under study (BV-2, hcmec/D3, and U87) presented different reactions to t-BOOH. In general, quercetin-biapigenin PCL-loaded nanoparticles were able to minimize compound toxicity they convey, regardless the cell line. Quercetin-biapigenin PCL-loaded nanoparticles (Papp of approximately 80 × 10–6 cm/s) revealed to be more permeable than free compounds (Papp of approximately 50 × 10–6 cm/s). As of our knowledge, this is the first report of quercetin-biapigenin PCL-loaded nanoparticle activity in brain cells. It is also the first determining its permeability through BBB, as an effective nanocarrier for brain delivery Graphical AbstractKeywords
This publication has 68 references indexed in Scilit:
- The hCMEC/D3 cell line as a model of the human blood brain barrierFluids and Barriers of the CNS, 2013
- Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell modelsJournal of Neuroscience Methods, 2011
- Bioactive Electrospun Scaffolds Delivering Growth Factors and Genes for Tissue Engineering ApplicationsPharmaceutical Research, 2010
- Balancing Selection Maintains a Form of ERAP2 that Undergoes Nonsense-Mediated Decay and Affects Antigen PresentationPLOS Genetics, 2010
- Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and DiagnosisPharmaceutical Research, 2010
- U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell LinePLOS Genetics, 2010
- Quercetin promotes degradation of survivin and thereby enhances death-receptor–mediated apoptosis in glioma cellsNeuro-Oncology, 2009
- Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's diseaseThe Journal of Nutritional Biochemistry, 2009
- Influence of Hypericum perforatum extract and its single compounds on amyloid-β mediated toxicity in microglial cellsLife Sciences, 2007
- Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extractsFood Chemistry, 2005